|
[1(n)-3H]Farnesyl pyrophosphate, triammonium salt |
|
|
|
Ethanol water 1:1 solution containing 100 mM ammonium bicarbonate. |
|
|
555-740 GBq/mmol, 15-20
Ci/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
| |
|
|
|
|
|
|
|
Freeze-dried solid. |
|
|
5.55-9.25 MBq/mg, 150-250
µCi/mg. |
|
| |
|
|
|
|
[125I]Fibroblast growth factor, basic, human recombinant |
|
|
|
Freeze-dried solid. |
|
|
29.6-51.8 TBq/mmol, 800-1400
Ci/mmol. |
|
|
Limited availability. |
|
| |
|
|
|
|
[N-methyl-3H]Flunitrazepam |
|
|
|
Ethanol solution. |
|
|
2.59-3.33 TBq/mmol, 70-90
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[3',5',7,9-3H]Folic acid, potassium salt |
|
|
|
1% potassium ascorbate solution, pH 6. |
|
|
0.74-1.85 TBq/mmol, 20-50
Ci/mmol. |
|
|
37 MBq/ml, 1 mCi/ml. |
|
| |
|
|
|
|
[14C]Formaldehyde (aqueous) |
|
|
|
1-3% Aqueous solution in
sealed ampoule. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 4 weeks from date of order. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
| |
|
|
|
|
[14C]Formic acid, sodium salt |
|
|
|
Solid in screw capped vial. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 1 week from date of order. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
| |
|
|
|
|
[14C]Formic acid, sodium salt |
|
|
|
Solid in screw capped vial. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 1 week from date of order. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
| |
|
|
|
|
[14C]Formic acid, sodium salt |
|
|
|
Solid in screw capped vial. |
|
|
1.85-2.29 GBq/mmol, 50-62 mCi/mmol. |
|
|
Available 1 week from date of order. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
|
When stored as recommended, has been shown to be usable for at least 2
months. |
|
| |
|
|
|
|
[125I]Fractalkine (liquid in dry ice) |
|
|
|
50 mM sodium acetate solution, pH 4.2 containing 5% sucrose and 0.5%
BSA. |
|
|
Specific activity: ~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
|
~ 3.7 MBq/ml, ~ 100 µCi/ml. |
|
|
Kd = 3.4 pM
(CX3CR1/CHO membrane)(3). |
|
|
[125I]Fractalkine
, human recombinant is supplied as a freeze-dried solid in 370 kBq, 10
µCi and 925 kBq, 25 µCi pack sizes. |
|
|
Made to order, please inquire for availability. |
|
| |
|
|
|
|
|
|
|
Freeze-dried in citrate buffer. |
|
| |
|
|
~ 74 TBq/mmol, ~ 2000 Ci/mmol. |
|
| |
|
|
Please inquire for availability. |
|
| |
|
|
When ordering, quote code number IM326. |
|
| |
|
|
For a full list of Receptor Ligands, see Ligand Selection Guides. |
|
| |
|
|
|
|
|
|
|
Aqueous solution containing 3% ethanol, sterilized. |
|
|
8.51-13.7 GBq/mmol, 230-370
mCi/mmol. |
|
|
7.4 MBq/ml, 200 µCi/ml. |
|
+32 1658 9045
+32 1650 9045
